ZENVIA INC - A (ZENV)

KYG9889V1014 - Common Stock

1.21  -0.04 (-2.81%)

After market: 1.28 +0.07 (+5.79%)

Fundamental Rating

2

ZENV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 281 industry peers in the Software industry. ZENV has a bad profitability rating. Also its financial health evaluation is rather negative. ZENV is valied quite expensively at the moment, while it does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year ZENV has reported negative net income.
ZENV had a positive operating cash flow in the past year.
ZENV had negative earnings in 4 of the past 5 years.
Of the past 5 years ZENV 4 years had a positive operating cash flow.

1.2 Ratios

ZENV has a Return On Assets of -6.47%. This is comparable to the rest of the industry: ZENV outperforms 46.26% of its industry peers.
ZENV has a Return On Equity (-14.08%) which is in line with its industry peers.
Industry RankSector Rank
ROA -6.47%
ROE -14.08%
ROIC N/A
ROA(3y)-6.48%
ROA(5y)-3.73%
ROE(3y)-12.02%
ROE(5y)-8.14%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ZENV has a Gross Margin of 39.67%. This is in the lower half of the industry: ZENV underperforms 76.16% of its industry peers.
In the last couple of years the Gross Margin of ZENV has grown nicely.
ZENV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.22%
GM growth 5Y4.61%

1

2. Health

2.1 Basic Checks

ZENV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZENV has been increased compared to 1 year ago.
Compared to 1 year ago, ZENV has an improved debt to assets ratio.

2.2 Solvency

ZENV has an Altman-Z score of 0.35. This is a bad value and indicates that ZENV is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.35, ZENV is not doing good in the industry: 70.46% of the companies in the same industry are doing better.
ZENV has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
ZENV's Debt to Equity ratio of 0.07 is in line compared to the rest of the industry. ZENV outperforms 55.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 0.35
ROIC/WACCN/A
WACC17.68%

2.3 Liquidity

A Current Ratio of 0.49 indicates that ZENV may have some problems paying its short term obligations.
ZENV has a worse Current ratio (0.49) than 92.88% of its industry peers.
ZENV has a Quick Ratio of 0.49. This is a bad value and indicates that ZENV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.49, ZENV is not doing good in the industry: 92.17% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.49

6

3. Growth

3.1 Past

ZENV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.15%, which is quite impressive.
ZENV shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.93%.
The Revenue has been growing by 23.92% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)49.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.17%
Revenue 1Y (TTM)20.93%
Revenue growth 3Y23.41%
Revenue growth 5Y23.92%
Sales Q2Q%19.83%

3.2 Future

ZENV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.88% yearly.
The Revenue is expected to grow by 12.38% on average over the next years. This is quite good.
EPS Next Y13.04%
EPS Next 2Y47.26%
EPS Next 3Y36.88%
EPS Next 5YN/A
Revenue Next Year15.67%
Revenue Next 2Y13.16%
Revenue Next 3Y12.38%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZENV. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 46.11 indicates a quite expensive valuation of ZENV.
The rest of the industry has a similar Price/Forward Earnings ratio as ZENV.
ZENV is valuated expensively when we compare the Price/Forward Earnings ratio to 23.28, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 46.11

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ZENV is valued cheaper than 96.80% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.23

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ZENV does not grow enough to justify the current Price/Earnings ratio.
ZENV's earnings are expected to grow with 36.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.26%
EPS Next 3Y36.88%

0

5. Dividend

5.1 Amount

No dividends for ZENV!.
Industry RankSector Rank
Dividend Yield N/A

ZENVIA INC - A

NASDAQ:ZENV (11/4/2024, 8:00:02 PM)

After market: 1.28 +0.07 (+5.79%)

1.21

-0.04 (-2.81%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap62.59M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 46.11
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.47%
ROE -14.08%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 39.67%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.49
Quick Ratio 0.49
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)49.15%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y13.04%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)20.93%
Revenue growth 3Y23.41%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y